umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma: A new era in the treatment of malignant brain tumours?
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
2009 (English)In: Acta Oncol, ISSN 1651-226X, Vol. 48, no 1, 6-8 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2009. Vol. 48, no 1, 6-8 p.
Identifiers
URN: urn:nbn:se:umu:diva-11500DOI: doi:10.1080/02841860802468112PubMedID: 18932097OAI: oai:DiVA.org:umu-11500DiVA: diva2:151171
Available from: 2009-01-13 Created: 2009-01-13 Last updated: 2011-07-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Henriksson, RogerBergström, PerJohansson, MikaelSandström, Maria
By organisation
Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 88 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf